(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Monetary Freedom Guide: Plan Your Future01.01.1 - 2Accomplishing Balance between fun and serious activities: Procedures for a Better Life06.06.2024
- 3I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.17.12.2025
- 4Knesset FADC extends emergency draft for 280,000 IDF reservists until January 108.12.2025
- 56 Savvy Locks for Lofts06.06.2024
- Exploring Programming Greatness: A Survey of \Easy to use Connection points\
- Vote In favor of Your Number one Kind Of Food Conveyance Administration
- Flu season is ramping up, and some experts are "pretty worried"
- Figure out How to Establish a long term connection with Your Handshake
- Poll: 62% of Americans would oppose U.S. military action in Greenland
- Climate leaders are talking about 'overshoot' into warming danger zone. Here's what it means
- Figure out How to Keep up with and Clean Your Brilliant Bed for Ideal Execution
- Dick Van Dyke shares his secrets to longevity as he turns 100
- Pick Your #1 Japanese Food
